Founded in 2015, Tempus is a US-based health-technology company that uses artificial intelligence and data science to help physicians make more informed treatment decisions in real time. The company focuses on making clinical and molecular data actionable, with particular emphasis on oncology, clinical trials, and medical research. Its core technical domains include AI, data science, genomic sequencing, and clinical data analysis.
Tempus connects with a significant share of the US healthcare ecosystem: it has partnerships with approximately 65% of academic medical centers and reaches more than 50% of oncologists in the United States. The company's product portfolio includes Tempus One, an AI-enabled clinical assistant; Lens, a data platform; and a suite of genomic sequencing diagnostic assays.
The company's culture emphasises impact and collaboration over hierarchy and face-time. Its teams bring together a mix of disciplines, including biology, data science, engineering, and clinical expertise, united by the belief that the right data at the right time can meaningfully change a patient's treatment path.
